BridgeBio Oncology Therapeutics Inc. (BBOT) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BridgeBio Oncology Therap...

    NASDAQ: BBOT · Real-Time Price · USD
    11.47
    -0.23 (-1.97%)
    At close: Sep 29, 2025, 3:59 PM
    11.35
    -1.05%
    After-hours: Sep 29, 2025, 07:29 PM EDT

    BridgeBio Oncology Therapeutics Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a n/a
    Cost of Revenue
    		 n/a n/a n/a n/a
    Gross Profit
    		 n/a n/a n/a n/a
    Operating Income
    		 -584K -41.69K n/a -43.36K
    Interest Income
    		 8.46M n/a n/a n/a
    Pretax Income
    		 7.6M -41.69K -3.52K -43.36K
    Net Income
    		 7.6M -41.69K -3.52K -43.36K
    Selling & General & Admin
    		 584.39K n/a n/a 43.36K
    Research & Development
    		 n/a n/a n/a n/a
    Other Expenses
    		 n/a 41.69K n/a n/a
    Operating Expenses
    		 584.39K 41.69K 3.52K 43.36K
    Interest Expense
    		 n/a n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a
    Cost & Expenses
    		 584.39K 41.69K 3.52K 43.36K
    Income Tax Expense
    		 n/a n/a n/a n/a
    Shares Outstanding (Basic)
    		 16.64M 20.48M 20.48M 20.48M
    Shares Outstanding (Diluted)
    		 16.64M 20.48M 20.48M 20.48M
    EPS (Basic)
    		 0.46 -0.00 n/a -0.00
    EPS (Diluted)
    		 0.46 -0.00 n/a -0.00
    EBITDA
    		 7.6M -41.69K -3.52K -43.36K
    EBIT
    		 7.6M -41.69K n/a -43.36K
    Depreciation & Amortization
    		 n/a n/a n/a n/a

    Add to Watchlist